Kirsten Harvey
University College London(GB)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Wnt/β-catenin signaling in development and cancer, Neuroscience and Neuropharmacology Research, Cellular transport and secretion, Neurological diseases and metabolism
Most-Cited Works
- → Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1(2004)3,437 cited
- → Kinase activity is required for the toxic effects of mutant LRRK2/dardarin(2006)744 cited
- → GlyR α3: An Essential Target for Spinal PGE 2 -Mediated Inflammatory Pain Sensitization(2004)602 cited
- → Neuroligin 2 Drives Postsynaptic Assembly at Perisomatic Inhibitory Synapses through Gephyrin and Collybistin(2009)486 cited
- → Increased spatiotemporal resolution reveals highly dynamic dense tubular matrices in the peripheral ER(2016)479 cited
- → The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1(2007)467 cited
- → Highly effective SNP-based association mapping and management of recessive defects in livestock(2008)343 cited
- → The GDP-GTP Exchange Factor Collybistin: An Essential Determinant of Neuronal Gephyrin Clustering(2004)259 cited
- → Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease(2006)233 cited
- → Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome(2021)207 cited